Kymera Therapeutics, Inc. Common Stock
KYMR Real Time Price USDRecent trades of KYMR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by KYMR's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
KYMR Revenue by Segment or Geography
New patents grants
-
Patent Title: Irak4 degraders and synthesis thereof Jan. 07, 2025
-
Patent Title: Irak4 degraders and uses thereof Dec. 24, 2024
-
Patent Title: Irak degraders and uses thereof Dec. 17, 2024
-
Patent Title: Irak degraders and uses thereof Nov. 26, 2024
-
Patent Title: Cdk2 degraders and uses thereof Sep. 24, 2024
-
Patent Title: Irak degraders and uses thereof Sep. 17, 2024
-
Patent Title: Stat degraders and uses thereof Sep. 03, 2024
-
Patent Title: Protein degraders and uses thereof Jun. 11, 2024
-
Patent Title: Crbn ligands and uses thereof Mar. 19, 2024
-
Patent Title: Mdm2 degraders and uses thereof Mar. 19, 2024
-
Patent Title: Tricyclic crbn ligands and uses thereof Feb. 13, 2024
-
Patent Title: Methods of treating mutant lymphomas Jan. 02, 2024
-
Patent Title: Irak degraders and uses thereof Nov. 07, 2023
-
Patent Title: Irak degraders and uses thereof Oct. 10, 2023
-
Patent Title: Irak4 degraders and uses thereof Oct. 03, 2023
-
Patent Title: Stat degraders and uses thereof Sep. 05, 2023
-
Patent Title: Irak degraders and uses thereof Aug. 15, 2023
-
Patent Title: Irak degraders and uses thereof Jul. 25, 2023
-
Patent Title: Crystalline forms of irak degraders Jun. 27, 2023
-
Patent Title: Smarca degraders and uses thereof Jun. 20, 2023
-
Patent Title: Protein degraders and uses thereof Apr. 11, 2023
-
Patent Title: Irak degraders and uses thereof Feb. 28, 2023
-
Patent Title: Crbn ligands and uses thereof Nov. 29, 2022
-
Patent Title: Stat degraders and uses thereof Nov. 01, 2022
-
Patent Title: Protein degraders and uses thereof Nov. 01, 2022
-
Patent Title: Crbn ligands and uses thereof Jun. 14, 2022
-
Patent Title: Irak degraders and uses thereof Jun. 07, 2022
-
Patent Title: Irak degraders and uses thereof May. 03, 2022
-
Patent Title: Tricyclic crbn ligands and uses thereof Apr. 05, 2022
-
Patent Title: Irak degraders and uses thereof Sep. 14, 2021
-
Patent Title: Irak degraders and uses thereof Dec. 29, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to KYMR
Number of mentions of KYMR in WallStreetBets Daily Discussion
Recent picks made for KYMR stock on CNBC
ETFs with the largest estimated holdings in KYMR
|
Shareholder
|
Shares Held
|
|---|
- Who owns $KYMR stock?
- Who owns the most shares of $KYMR stock?
- What funds own $KYMR stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view KYMR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.